ReviewOncoTargets and therapy2021

Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 Inhibitors.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.